Skip to main content
Erschienen in: Osteoporosis International 1/2018

03.10.2017 | Case Report

A novel dominant COL11A1 mutation in a child with Stickler syndrome type II is associated with recurrent fractures

verfasst von: M. G. Vogiatzi, D. Li, L. Tian, J. P. Garifallou, C. E. Kim, H. Hakonarson, M. A. Levine

Erschienen in: Osteoporosis International | Ausgabe 1/2018

Einloggen, um Zugang zu erhalten

Abstract

Summary

This case describes a child with blindness, recurrent low-impact fractures, low bone mass, and intermittent joint pain who was found to have a novel missense mutation in COL11A1, consistent with Stickler syndrome type II. The case illustrates the phenotypic variability of the syndrome, which may include increased fragility in childhood.

Introduction

Stickler syndrome type II is an autosomal dominant disorder caused by mutations in the gene that encodes the type XI collagen chain α1 (COL11A1). Manifestations include craniofacial dysmorphology and ocular abnormalities that may lead to blindness, hearing loss, and skeletal anomalies that range from joint pain and arthritis to scoliosis and hypermobility.

Methods

Herein, we describe a child who carried the presumed diagnosis of osteoporosis-pseudoglioma syndrome because of the combined findings of recurrent low-impact fractures due to low bone mass and blindness. The child also suffered from joint pain but had no facial dysmorphism or hearing loss.

Results

Targeted sequencing and deletion analysis of the LRP5, COL1A1, and COL1A2 genes failed to identify any mutations, and whole exome sequence analysis revealed a novel missense mutation (c.3032C>A:p.P1011Q) in COL11A1, consistent with Stickler type II.

Conclusion

This case highlights the phenotypic variability of Stickler type II, broadens the list of differential diagnosis of increased bone fragility in childhood, and highlights utility of unbiased genetic testing towards establishing the correct diagnosis in children with frequent fractures.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Robin NH, Moran RT, Ala-Kokko L (2000) Stickler syndrome. In: Pagon RA, Adam MP, Ardinger HH, Wallace SE, Amemiya A, Bean LJH, Bird TD, Fong CT, Mefford HC, Smith RJH, Stephens K, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2017. Jun 09 [updated March 16, 2017] Robin NH, Moran RT, Ala-Kokko L (2000) Stickler syndrome. In: Pagon RA, Adam MP, Ardinger HH, Wallace SE, Amemiya A, Bean LJH, Bird TD, Fong CT, Mefford HC, Smith RJH, Stephens K, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2017. Jun 09 [updated March 16, 2017]
2.
Zurück zum Zitat Acke FR, Malfait F, Vanakker OM, Steyaert W, De Leeneer K, Mortier G, Dhooge I, De Paepe A, De Leenheer EM, Coucke PJ (2014) Novel pathogenic COL11A1/COL11A2 variants in Stickler syndrome detected by targeted NGS and exome sequencing. Mol Genet Metab 113(3):230–235CrossRefPubMed Acke FR, Malfait F, Vanakker OM, Steyaert W, De Leeneer K, Mortier G, Dhooge I, De Paepe A, De Leenheer EM, Coucke PJ (2014) Novel pathogenic COL11A1/COL11A2 variants in Stickler syndrome detected by targeted NGS and exome sequencing. Mol Genet Metab 113(3):230–235CrossRefPubMed
3.
Zurück zum Zitat Wang X, Jia X, Xiao X, Li S, Li J, Li Y, Wei Y, Liang X, Guo X (2016) Mutation survey and genotype-phenotype analysis of COL2A1 and COL11A1 genes in 16 Chinese patients with Stickler syndrome. Mol Vis 23(22):697–704 Wang X, Jia X, Xiao X, Li S, Li J, Li Y, Wei Y, Liang X, Guo X (2016) Mutation survey and genotype-phenotype analysis of COL2A1 and COL11A1 genes in 16 Chinese patients with Stickler syndrome. Mol Vis 23(22):697–704
6.
Zurück zum Zitat Laine CM, Chung BD, Susic M, Prescott T, Semler O, Fiskerstrand T, D'Eufemia P, Castori M, Pekkinen M, Sochett E, Cole WG, Netzer C, Mäkitie O (2011) Novel mutations affecting LRP5 splicing in patients with osteoporosis-pseudoglioma syndrome (OPPG). Eur J Hum Genet 19(8):875–881CrossRefPubMedPubMedCentral Laine CM, Chung BD, Susic M, Prescott T, Semler O, Fiskerstrand T, D'Eufemia P, Castori M, Pekkinen M, Sochett E, Cole WG, Netzer C, Mäkitie O (2011) Novel mutations affecting LRP5 splicing in patients with osteoporosis-pseudoglioma syndrome (OPPG). Eur J Hum Genet 19(8):875–881CrossRefPubMedPubMedCentral
7.
Zurück zum Zitat Li D, Opas EE, Tuluc F, Metzger DL, Hou C, Hakonarson H, Levine MA (2014) Autosomal dominant hypoparathyroidism caused by germline mutation in GNA11: phenotypic and molecular characterization. J Clin Endocrinol Metab 99(9):E1774–E1783CrossRefPubMedPubMedCentral Li D, Opas EE, Tuluc F, Metzger DL, Hou C, Hakonarson H, Levine MA (2014) Autosomal dominant hypoparathyroidism caused by germline mutation in GNA11: phenotypic and molecular characterization. J Clin Endocrinol Metab 99(9):E1774–E1783CrossRefPubMedPubMedCentral
8.
Zurück zum Zitat Li D, Yuan H, Ortiz-Gonzalez XR, Marsh ED, Tian L, McCormick EM, Kosobucki GJ, Chen W, Schulien AJ, Chiavacci R, Tankovic A, Naase C, Brueckner F, von Stülpnagel-Steinbeis C, Hu C, Kusumoto H, Hedrich UB, Elsen G, Hörtnagel K, Aizenman E, Lemke JR, Hakonarson H, Traynelis SF, Falk MJ (2016) GRIN2D recurrent de novo dominant mutation causes a severe epileptic encephalopathy treatable with NMDA receptor channel blockers. Am J Hum Genet 99(4):802–816CrossRefPubMedPubMedCentral Li D, Yuan H, Ortiz-Gonzalez XR, Marsh ED, Tian L, McCormick EM, Kosobucki GJ, Chen W, Schulien AJ, Chiavacci R, Tankovic A, Naase C, Brueckner F, von Stülpnagel-Steinbeis C, Hu C, Kusumoto H, Hedrich UB, Elsen G, Hörtnagel K, Aizenman E, Lemke JR, Hakonarson H, Traynelis SF, Falk MJ (2016) GRIN2D recurrent de novo dominant mutation causes a severe epileptic encephalopathy treatable with NMDA receptor channel blockers. Am J Hum Genet 99(4):802–816CrossRefPubMedPubMedCentral
9.
Zurück zum Zitat Temin HM (1989) Retrovirus vectors for study of biochemical processes. Biochem Int 1989 18(1):1–6 Temin HM (1989) Retrovirus vectors for study of biochemical processes. Biochem Int 1989 18(1):1–6
10.
Zurück zum Zitat Rocha-Braz MG, Ferraz-de-Souza B (2016) Genetics of osteoporosis: searching for candidate genes for bone fragility. Arch Endocrinol Metab 60(4):391–401CrossRefPubMed Rocha-Braz MG, Ferraz-de-Souza B (2016) Genetics of osteoporosis: searching for candidate genes for bone fragility. Arch Endocrinol Metab 60(4):391–401CrossRefPubMed
11.
Zurück zum Zitat Marini JC, Reich A, Smith SM (2014) Osteogenesis imperfecta due to mutations in non-collagenous genes: lessons in the biology of bone formation. Curr Opin Pediatr 26(4):500–507CrossRefPubMedPubMedCentral Marini JC, Reich A, Smith SM (2014) Osteogenesis imperfecta due to mutations in non-collagenous genes: lessons in the biology of bone formation. Curr Opin Pediatr 26(4):500–507CrossRefPubMedPubMedCentral
12.
Zurück zum Zitat Symoens S, Barnes AM, Gistelinck C, Malfait F, Guillemyn B, Steyaert W, Syx D et al (2015) Genetic defects in TAPT1 disrupt ciliogenesis and cause a complex lethal osteochondrodysplasia. Am J Hum Genet 97(4):521–534CrossRefPubMedPubMedCentral Symoens S, Barnes AM, Gistelinck C, Malfait F, Guillemyn B, Steyaert W, Syx D et al (2015) Genetic defects in TAPT1 disrupt ciliogenesis and cause a complex lethal osteochondrodysplasia. Am J Hum Genet 97(4):521–534CrossRefPubMedPubMedCentral
13.
Zurück zum Zitat Khalifa O, Imtiaz F, Ramzan K, Allam R, Hemidan AA, Faqeih E, Abuharb G, Balobaid A, Sakati N, Owain MA (2014) Marshall syndrome: further evidence of a distinct phenotypic entity and report of new findings. Am J Med Genet A 164A(10):2601–2606CrossRefPubMed Khalifa O, Imtiaz F, Ramzan K, Allam R, Hemidan AA, Faqeih E, Abuharb G, Balobaid A, Sakati N, Owain MA (2014) Marshall syndrome: further evidence of a distinct phenotypic entity and report of new findings. Am J Med Genet A 164A(10):2601–2606CrossRefPubMed
14.
Zurück zum Zitat Hufnagel SB, Weaver KN, Hufnagel RB, Bader PI, Schorry EK, Hopkin RJ (2014) A novel dominant COL11A1 mutation resulting in a severe skeletal dysplasia. Am J Med Genet A 164A(10):2607–2612CrossRefPubMed Hufnagel SB, Weaver KN, Hufnagel RB, Bader PI, Schorry EK, Hopkin RJ (2014) A novel dominant COL11A1 mutation resulting in a severe skeletal dysplasia. Am J Med Genet A 164A(10):2607–2612CrossRefPubMed
15.
Zurück zum Zitat Morris NP, Bachinger HP (1987) Type XI collagen is a heterotrimers with the composition (1 alpha, 2 alpha, 3 alpha) retaining non-triple-helical domains. J Biol Chem 262:11345–11350PubMed Morris NP, Bachinger HP (1987) Type XI collagen is a heterotrimers with the composition (1 alpha, 2 alpha, 3 alpha) retaining non-triple-helical domains. J Biol Chem 262:11345–11350PubMed
16.
Zurück zum Zitat Kramer RZ(1), Bella J, Mayville P, Brodsky B, Berman HM (1999) Sequence dependent conformational variations of collagen triple-helical structure. Nat Struct Biol 6(5):454–457CrossRefPubMed Kramer RZ(1), Bella J, Mayville P, Brodsky B, Berman HM (1999) Sequence dependent conformational variations of collagen triple-helical structure. Nat Struct Biol 6(5):454–457CrossRefPubMed
17.
Zurück zum Zitat Blaschke UK, Eikenberry EF, Hulmes DJ, Galla HJ, Bruckner P (2000) Collagen XI nucleates self-assembly and limits lateral growth of cartilage fibrils. J Biol Chem 275:10370–10378CrossRefPubMed Blaschke UK, Eikenberry EF, Hulmes DJ, Galla HJ, Bruckner P (2000) Collagen XI nucleates self-assembly and limits lateral growth of cartilage fibrils. J Biol Chem 275:10370–10378CrossRefPubMed
18.
Zurück zum Zitat Hafez A, Squires R, Pedracini A, Joshi A, Seegmiller RE, Oxford JT (2015) Col11a1 regulates bone microarchitecture during embryonic development. J Dev Biol 3(4):158–176CrossRefPubMedPubMedCentral Hafez A, Squires R, Pedracini A, Joshi A, Seegmiller RE, Oxford JT (2015) Col11a1 regulates bone microarchitecture during embryonic development. J Dev Biol 3(4):158–176CrossRefPubMedPubMedCentral
19.
Zurück zum Zitat Niyibizi C, Eyre DR (1989) Identification of the cartilage α1(XI) chain in type V collagen form bovine bone. FEBS Lett 242:314–318CrossRefPubMed Niyibizi C, Eyre DR (1989) Identification of the cartilage α1(XI) chain in type V collagen form bovine bone. FEBS Lett 242:314–318CrossRefPubMed
20.
Zurück zum Zitat Kahler RA, Yingst SM, Hoeppner LH, Jensen ED, Krawczak D, Oxford JT, Westendorf JJ (2008) Collagen 11a1 is indirectly activated by lymphocyte enhancer-binding factor 1(lef1) and negatively regulated osteoblast maturation. Matrix Biol 27:330–338CrossRefPubMedPubMedCentral Kahler RA, Yingst SM, Hoeppner LH, Jensen ED, Krawczak D, Oxford JT, Westendorf JJ (2008) Collagen 11a1 is indirectly activated by lymphocyte enhancer-binding factor 1(lef1) and negatively regulated osteoblast maturation. Matrix Biol 27:330–338CrossRefPubMedPubMedCentral
21.
Zurück zum Zitat Al Kaissi A, Roschger P, Nawrot-Wawrzyniak K, Krebs A, Grill F, Klaushofer K (2010) Evidence of reduced bone turnover and disturbed mineralization process in a boy with Stickler syndrome. 86(2):126–31 Al Kaissi A, Roschger P, Nawrot-Wawrzyniak K, Krebs A, Grill F, Klaushofer K (2010) Evidence of reduced bone turnover and disturbed mineralization process in a boy with Stickler syndrome. 86(2):126–31
22.
Zurück zum Zitat Insalaco P, Legrand E, Bouvard B, Audran M (2017) Osteoporosis in Stickler syndrome. A new family case with bone histology study. Morphologie 101(332):33–38CrossRefPubMed Insalaco P, Legrand E, Bouvard B, Audran M (2017) Osteoporosis in Stickler syndrome. A new family case with bone histology study. Morphologie 101(332):33–38CrossRefPubMed
Metadaten
Titel
A novel dominant COL11A1 mutation in a child with Stickler syndrome type II is associated with recurrent fractures
verfasst von
M. G. Vogiatzi
D. Li
L. Tian
J. P. Garifallou
C. E. Kim
H. Hakonarson
M. A. Levine
Publikationsdatum
03.10.2017
Verlag
Springer London
Erschienen in
Osteoporosis International / Ausgabe 1/2018
Print ISSN: 0937-941X
Elektronische ISSN: 1433-2965
DOI
https://doi.org/10.1007/s00198-017-4229-3

Weitere Artikel der Ausgabe 1/2018

Osteoporosis International 1/2018 Zur Ausgabe

Arthropedia

Grundlagenwissen der Arthroskopie und Gelenkchirurgie. Erweitert durch Fallbeispiele, Videos und Abbildungen. 
» Jetzt entdecken

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Arthroskopie kann Knieprothese nicht hinauszögern

25.04.2024 Gonarthrose Nachrichten

Ein arthroskopischer Eingriff bei Kniearthrose macht im Hinblick darauf, ob und wann ein Gelenkersatz fällig wird, offenbar keinen Unterschied.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Ärztliche Empathie hilft gegen Rückenschmerzen

23.04.2024 Leitsymptom Rückenschmerzen Nachrichten

Personen mit chronischen Rückenschmerzen, die von einfühlsamen Ärzten und Ärztinnen betreut werden, berichten über weniger Beschwerden und eine bessere Lebensqualität.

Update Orthopädie und Unfallchirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.